Immune cell therapy tested for Tough-to-Treat cancers
NCT ID NCT04627740
Summary
This small, early-stage study tested a new cell therapy for patients with advanced solid tumors that had stopped responding to standard treatments. Doctors collected immune cells from patients, modified them in a lab to target a specific protein (ALPP) found on their tumors, and then infused them back. The main goals were to check if this treatment was safe and to see if it could help control the cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Department of Oncology, Xinqiao Hospital
Chongqing, Chongqing Municipality, 400037, China
Conditions
Explore the condition pages connected to this study.